Organic Consumers Association

Campaigning for health, justice, sustainability, peace, and democracy

High Drama, High Stakes

Raised voices, accusations, drama and controversy marked last week’s four-day meetings, convened by the U.S. Environmental Protection Agency (EPA) to determine whether or not regulators should re-approve glyphosate, the key ingredient in Monsanto’s Roundup herbicide, for use in the U.S.

Reporting for Huffington Post, US Right to Know’s Carey Gillam wrote:

The EPA’s determination is crucial on many fronts - Monsanto is currently defending itself against more than three dozen lawsuits claiming glyphosate-based Roundup gave people non-Hodgkin lymphoma (NHL), a type of blood cancer; both the EPA and the European Union are assessing re-registrations of glyphosate to determine if limits should be placed on the chemical; and Monsanto is attempting a $66 billion merger with German-based Bayer.

Below are a few reports from the meetings last week. But the bottom line is this: Is there anyone in the EPA who has the will to do what we, the taxpayers, pay them to do? Which is to place a higher priority on the health and rights of the people, than on the profits of Monsanto?

We won’t know for at least another three months. But this we do know: The stakes are high.

Read ‘Future of Top Pesticide Uncertain after Grueling Cancer Review’ 

Read ‘Cancer Questions, Controversy and Chorus at EPA Glyphosate Meetings’

Read ‘EPA Poised to Sign Off on Monsanto’s Glyphosate, Despite Warnings by Independent Scientists’ 

Get Local

Find News and Action for your state: